Mizuho Securities’ healthcare analyst Irina Rivkind Koffler weighed in today with her views on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after Citron Research said in a report that it …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and biopharmaceutical company Relypsa Inc (NASDAQ:RLYP), as both stocks …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Lexington biotech company Synta Pharmaceuticals Corp. (NASDAQ:SNTA), as shares of both companies fell …
Canaccord’s healthcare analyst Neil Maruoka weighed in today with his views on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), following a bear report by Citron Research implying that …
By Terry Chrisomalis Sarepta Therapeutics Inc On October 1, 2015 shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) ended the day up approximately 22 % …
Over the past two weeks, shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) took a steep decline over concerns of price gouging that was recently …
By Terry Chrisomalis RXi Pharmaceuticals Corp On August 31, 2015 RXi Pharmaceuticals Corp (NASDAQ:RXII) announced that the 30-day review period for its IND of RXI-109 …
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced that Valeant submitted a New Drug Application to the U.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription products. The company was …
GoPro Inc (NASDAQ:GPRO) shares increased +2.63% in pre-market trading to $54.
